DoubleBlind Magazine: Microdosing MDMA: The Good, Bad & Everything In Between
Originally appearing here (Archived)
MAPS in the Media
Behavioral Health Business: Why 2023 Could be a Pivotal Year for Psychedelic-Assisted Treatment
Summary: Behavioral Health Business publishes an overview of the increasing popularity of psychedelics due largely to the promising psychedelic-assisted research results taking place. Author Laura Lovett …
Benzinga: MDMA For PTSD Shows Positive Results In Important Clinical Trial: Are Psychedelic Treatments Around The Corner?
Originally appearing here (Archived)
Medium: How Microdosing Improved My Athletic Performance
Originally appearing here (Archived)
2 Bears 1 Cave Podcast: Body Hacks with Andrew Huberman
Summary: Andrew Huberman, Ph.D., mentions MAPS and MAPS Founder and Executive Director Rick Doblin, Ph.D., while being interviewed by Tom Segura on the 2 Bears, 1 Cave (YMHstudios) podcast at 39 minutes …
Psychology Today: Why Psychedelics Are Therapy’s Next Frontier
Originally appearing here (Archived)
The goop Pursuit: Healing in a Sick Society by Will Siu, M.D.
Summary: In “Healing in a Sick Society,” an episode of the Audible Original The goop Pursuit, Will Siu, M.D., courageously discusses his healing journey. I join Will to discuss the origins …
MDedge Psychiatry: More Support for MDMA-Assisted Therapy for PTSD
Originally appearing here (Archived)
LA Weekly: Psychedelics’ Use Studied for Alcohol, Drug Disorders
Originally appearing here (Archived)
Inverse: How Colorado’s Radical Decriminalization Efforts May Herald a New Era for Psychedelics
Originally appearing here (Archived)
MBL.IS: Great Atmosphere at a Conference on Thought-Provoking Topics
Originally appearing here (Archived)
Forbes: New Study Supports MDMA As A Treatment For PTSD
Summary: Forbes publishes an overview of the announcement surrounding a successful confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder (PTSD). “The Phase 3 confirmatory …